Somatosensory profiles in acute herpes zoster and predictors of postherpetic neuralgia
- PMID: 30585985
- DOI: 10.1097/j.pain.0000000000001467
Somatosensory profiles in acute herpes zoster and predictors of postherpetic neuralgia
Abstract
This prospective cohort study aimed to characterize the sensory profile during acute herpes zoster (AHZ) and to explore sensory signs as well as physical and psychosocial health as predictors for postherpetic neuralgia (PHN). Results of quantitative sensory testing of 74 patients with AHZ at the affected site and at the distant contralateral control site were compared to a healthy control group. Pain characteristics (Neuropathic Pain and Symptom Inventory and SES), physical functioning, and psychosocial health aspects (Pain Disability Index, SF-36, and STAI) were assessed by questionnaires. Patients with PHN (n = 13) at 6-month follow-up were compared to those without PHN (n = 45). Sensory signs at the affected site were thermal and vibratory hypesthesia, dynamic mechanical allodynia (DMA), pressure hyperalgesia, and high wind-up (18%-29%), as well as paradoxical heat sensations and pinprick hypalgesia (13.5%). The unaffected control site exhibited thermal and vibratory hypesthesia, DMA, and pressure hyperalgesia. Dynamic mechanical allodynia and pinprick hypalgesia were mutually exclusive. Postherpetic neuralgia was associated with DMA (38.5% vs 6.7%; P = 0.010) and vibratory hypesthesia (38.5% vs 11.1%; P = 0.036) at the control site, with mechanical gain and/or loss combined with normal thermal detection (affected site: 69.2% vs 31.1%; P = 0.023; control site: 53.8% vs 15.5%; P = 0.009). Pain Disability Index (P = 0.036) and SES affective pain perception scores (P = 0.031) were over 50% higher, and 6 of 8 SF-36 subscores were over 50% lower (P < 0.045) in PHN. Sensory profiles in AHZ indicate deafferentation and central but not peripheral sensitization. Sensory signs at distant body sites, strong affective pain perception, as well as reduced quality of life and physical functioning in the acute phase may reflect risk factors for the transition to PHN.
Similar articles
-
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes.Pain. 2010 Sep;150(3):439-450. doi: 10.1016/j.pain.2010.05.002. Pain. 2010. PMID: 20627413
-
Natural history of sensory function after herpes zoster.Pain. 2010 Jul;150(1):83-92. doi: 10.1016/j.pain.2010.04.005. Epub 2010 May 7. Pain. 2010. PMID: 20452122
-
Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms.Anesthesiology. 2000 Mar;92(3):691-8. doi: 10.1097/00000542-200003000-00013. Anesthesiology. 2000. PMID: 10719948 Clinical Trial.
-
Management of herpes zoster and post-herpetic neuralgia.Am J Clin Dermatol. 2013 Apr;14(2):77-85. doi: 10.1007/s40257-013-0011-2. Am J Clin Dermatol. 2013. PMID: 23456596 Review.
-
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia.J Pain. 2008 Jan;9(1 Suppl 1):S37-44. doi: 10.1016/j.jpain.2007.10.008. J Pain. 2008. PMID: 18166464 Review.
Cited by
-
Patient-reported quality of life in patients suffering from acute herpes zoster-a systematic review with meta-analysis.Br J Pain. 2022 Aug;16(4):404-419. doi: 10.1177/20494637211073050. Epub 2022 Feb 21. Br J Pain. 2022. PMID: 36032345 Free PMC article.
-
Genetics of causal relationships between circulating inflammatory proteins and postherpetic neuralgia: a bidirectional Mendelian randomization study.Front Neurol. 2024 Jun 21;15:1405694. doi: 10.3389/fneur.2024.1405694. eCollection 2024. Front Neurol. 2024. PMID: 38974683 Free PMC article.
-
Test-Retest and Inter-Examiner Reliability of a Novel Bedside Quantitative Sensory Testing Battery in Postherpetic Neuralgia Patients.J Pain. 2020 Jul-Aug;21(7-8):858-868. doi: 10.1016/j.jpain.2019.11.013. Epub 2019 Dec 11. J Pain. 2020. PMID: 31837446 Free PMC article.
-
Efficacy of extracorporeal shockwave therapy in the treatment of postherpetic neuralgia: A pilot study.Medicine (Baltimore). 2020 Mar;99(12):e19516. doi: 10.1097/MD.0000000000019516. Medicine (Baltimore). 2020. PMID: 32195953 Free PMC article.
-
HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING.Brain. 2024 Jul 5;147(7):2552-2565. doi: 10.1093/brain/awae053. Brain. 2024. PMID: 38366606 Free PMC article.
References
-
- Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH, Hansson P, Hatem SM, Krumova EK, Jensen TS, Maier C, Mick G, Rice AS, Rolke R, Treede RD, Serra J, Toelle T, Tugnoli V, Walk D, Walalce MS, Ware M, Yarnitsky D, Ziegler D. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. PAIN 2013;154:1807–19.
-
- Baron R, Haendler G, Schulte H. Afferent large fiber polyneuropathy predicts the development of postherpetic neuralgia. PAIN 1997;73:231–8.
-
- Baron R, Saguer M. Axon-reflex reactions in affected and homologous contralateral skin after unilateral peripheral injury of thoracic segmental nerves in humans. Neurosci Lett 1994;165:97–100.
-
- Baron R, Tölle TR, Gockel U, Brosz M, Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. PAIN 2009;146:34–40.
-
- Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F. Development and validation of the neuropathic pain symptom inventory. PAIN 2004;108:248–57.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical